Covid-19 (Recombinante) vaccine

· Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Covid-19 (Recombinante) vaccine, covering 2023-06-13 to 2023-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses. [Phase 4]

See pricing